CNY 26.15
(1.67%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.94 Billion CNY | 6.01% |
2022 | 9.38 Billion CNY | 79.99% |
2021 | 5.21 Billion CNY | 50.33% |
2020 | 3.46 Billion CNY | 73.81% |
2019 | 1.99 Billion CNY | 18.17% |
2018 | 1.68 Billion CNY | 13.52% |
2017 | 1.48 Billion CNY | 28.06% |
2016 | 1.16 Billion CNY | 11.3% |
2015 | 1.04 Billion CNY | 3.6% |
2014 | 1 Billion CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 10.36 Billion CNY | 3.09% |
2024 Q1 | 10.05 Billion CNY | 1.07% |
2024 Q3 | 10.7 Billion CNY | 3.27% |
2023 Q3 | 9.41 Billion CNY | 2.22% |
2023 FY | 9.94 Billion CNY | 6.01% |
2023 Q2 | 9.21 Billion CNY | -2.59% |
2023 Q4 | 9.94 Billion CNY | 5.62% |
2023 Q1 | 9.46 Billion CNY | 0.8% |
2022 FY | 9.38 Billion CNY | 79.99% |
2022 Q4 | 9.38 Billion CNY | 6.54% |
2022 Q3 | 8.8 Billion CNY | 31.35% |
2022 Q2 | 6.7 Billion CNY | 10.1% |
2022 Q1 | 6.09 Billion CNY | 16.82% |
2021 Q2 | 4.51 Billion CNY | 3.0% |
2021 FY | 5.21 Billion CNY | 50.33% |
2021 Q3 | 4.8 Billion CNY | 6.49% |
2021 Q4 | 5.21 Billion CNY | 8.42% |
2021 Q1 | 4.38 Billion CNY | 26.41% |
2020 Q4 | 3.46 Billion CNY | 44.97% |
2020 FY | 3.46 Billion CNY | 73.81% |
2020 Q3 | 2.39 Billion CNY | 8.46% |
2020 Q2 | 2.2 Billion CNY | 0.0% |
2020 Q1 | - CNY | -100.0% |
2019 Q4 | 1.99 Billion CNY | 0.0% |
2019 FY | 1.99 Billion CNY | 18.17% |
2018 FY | 1.68 Billion CNY | 13.52% |
2017 Q1 | 1.09 Billion CNY | 0.0% |
2017 Q4 | 1.48 Billion CNY | 0.0% |
2017 Q2 | 1.09 Billion CNY | 0.0% |
2017 FY | 1.48 Billion CNY | 28.06% |
2016 FY | 1.16 Billion CNY | 11.3% |
2015 FY | 1.04 Billion CNY | 3.6% |
2014 FY | 1 Billion CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 1.86 Billion CNY | -433.979% |
Jointown Pharmaceutical Group Co., Ltd | 92.78 Billion CNY | 89.278% |
LBX Pharmacy Chain Joint Stock Company | 22.2 Billion CNY | 55.185% |
Yifeng Pharmacy Chain Co., Ltd. | 24.13 Billion CNY | 58.781% |